An early switch from heparin to dabigatran, following standard clinical assessment, was both safe and effective in patients with intermediate-risk pulmonary embolism, according to study results published in Lancet Hematology. Although research conducted in the past decade has brought advances to anticoagulation treatment, including the development of direct oral anticoagulants (DOACs), it is unclear the […]